A unique paclitaxel-mediated modulation of the catalytic activity of topoisomerase IIalpha

V Dhawan1, D S Swaffar

  • 1Division of Basic Pharmaceutical Sciences, School of Pharmacy, Northeast Louisiana University, Monroe 71209, USA.

Anti-Cancer Drugs
|June 23, 1999
PubMed

Insights

Paclitaxel (Taxol) may target more than microtubules. This study shows paclitaxel directly interacts with topoisomerase II (Topo II), uniquely stimulating or inhibiting its activity, suggesting a novel mechanism of action for this cancer drug.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Paclitaxel (Taxol) is a microtubule-stabilizing agent used in cancer therapy.
  • Its precise mechanisms of cell death and high efficacy suggest potential additional molecular targets beyond microtubules.
  • Enhanced sensitivity of DNA repair-deficient cells to paclitaxel and Topo II poisons prompted investigation into paclitaxel's interaction with Topo II.

Purpose of the Study:

  • To investigate the hypothesis that paclitaxel alters topoisomerase II (Topo II) activity.
  • To characterize the in vitro effects of paclitaxel on Topo II catalytic function.

Main Methods:

  • Assessed Topo II activity by monitoring kinetoplast DNA decatenation and supercoiled plasmid DNA relaxation.
  • Examined the effects of varying paclitaxel concentrations on Topo II enzymatic activity.
  • Investigated whether paclitaxel interacts directly with Topo II, DNA, or DNA-Topo II complexes.

Main Results:

  • Low concentrations of paclitaxel (0.02-500 nM) stimulated Topo II catalytic activity.
  • High concentrations of paclitaxel (over 5 microM) inhibited Topo II activity.
  • Paclitaxel's effects on Topo II activity appear to result from direct interaction with the enzyme, not DNA or DNA-Topo II complexes.

Conclusions:

  • Paclitaxel exhibits unique, concentration-dependent effects on Topo II activity, distinct from classical Topo II poisons.
  • Evidence suggests a direct interaction between paclitaxel and Topo II.
  • This atypical interaction may contribute to paclitaxel's overall mechanism of action and efficacy in cancer treatment.

Related Concept Videos

DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...